Adma Biologics (ADMA) Share-based Compensation Growth (1y) (2012 - 2025)
Adma Biologics (ADMA) Share-based Compensation Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 118.32% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -40.86% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | -0.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.75% |
| Sep 30, 2025 | 58.76% |
| Jun 30, 2025 | 73.35% |
| Mar 31, 2025 | 115.97% |
| Dec 31, 2024 | 211.35% |
| Sep 30, 2024 | 87.55% |
| Jun 30, 2024 | 74.89% |
| Mar 31, 2024 | 92.88% |
| Dec 31, 2023 | 63.23% |
| Sep 30, 2023 | 29.05% |
| Jun 30, 2023 | 37.44% |
| Mar 31, 2023 | -32.37% |
| Dec 31, 2022 | -11.88% |
| Sep 30, 2022 | 90.84% |
| Jun 30, 2022 | 47.92% |
| Mar 31, 2022 | 110.06% |
| Dec 31, 2021 | 76.28% |
| Sep 30, 2021 | -11.17% |
| Jun 30, 2021 | 12.52% |
| Mar 31, 2021 | 15.50% |